Edit Entry | Edit CV

Cornel N. Stanciu, MD

Title(s)
Assistant Professor of Psychiatry

Additional Titles/Positions/Affiliations
Director of Addiction Services at New Hampshire Hospital

Department(s)
Psychiatry

Education
Residency:
Psychiatric Medicine -- East Carolina University, Greenville, NC

Fellowship:
Addiction Psychiatry -- Dartmouth-Hitchcock Medical Center, Lebanon, NH

Fellowship:
Electroconvulsive Therapy -- Duke University Medical Center, Durham, NC

Other Training:
Medical Review Officer (MRO) -- American Association of Medical Review Officers

Certified Physician Executive (CPE) -- American Association for Physician Leadership

Websites
https://www.researchgate.net/profile/Cornel_Stanciu

Contact Information

New Hampshire Hospital
36 Clinton Street
Concord NH 03301

Phone: (603)-271-5265
Email: Corneliu.Stanciu@dhhs.nh.gov


Professional Interests

- Kratom
- New designer drugs
- Cannabinoids
- Physician substance abuse / health programs
- Telemedicine models for delivery of addiction treatment
- Population-based addiction treatment models
- Chronotherapeutics

Mentoring Information

Available by request.

Biography

Cornel N. Stanciu, M.D., C.P.E., M.R.O. is an Assistant Professor of Psychiatry at Dartmouth’s Geisel School of Medicine and the Director of Addiction Services at New Hampshire Hospital.

As an Addiction Psychiatrist, Dr. Stanciu is involved in clinical care, research, and policy concerning services and treatments for people with addictive disorders. At the state level he served on the Therapeutic Cannabis Monitoring Oversight Board, and was appointed by the governor to the Board of Medicine’s Medical Review Subcommittee. Nationally, he is involved with several organizations, currently serving on the Board of Directors of the American Academy of Addiction Psychiatry as the Newsletter Editor. He earned prestigious fellowship credentials from both the American Psychiatric Association, and the American Society of Addiction Medicine and is a former Ruth Fox and Governors Institute on Substance Abuse scholar.
Throughout his career, Dr. Stanciu played an active role in academia having published over 40 papers on themes related to addictive disorders, particularly new psychoactive drugs, such as Kratom, and has received multiple awards for excellence in research and clinical care. His research was presented at numerous conferences, through live webinars, and cited in literature.

Furthermore, Dr. Stanciu’ s devotion to the field and commitment to downstream knowledge dissemination is exemplified through his most recently published book titled “Deciphering the Addicted Brain: A Guide to understanding and Helping a Loved One Towards Recovery”.


Selected Publications

 

Kratom Consumption Associated With Herb-Induced Liver Injury and a Pharmacokinetic Interaction: A Case Report.
Gnanasegaram S, Stanciu CN
Cureus. 2026 Mar;18(3):e106016. doi: 10.7759/cureus.106016. Epub 2026 Mar 28.
PMID: 42051846

Severe Early-Onset Withdrawal Following Intentional Use of Mitragynine Pseudoindoxyl: A Case Report and Emerging Clinical Considerations.
Stanciu CN
Cureus. 2026 Mar;18(3):e105224. doi: 10.7759/cureus.105224. Epub 2026 Mar 14.
PMID: 41982589

Substance Use Referrals Among Inpatients With Serious Mental Illness: Clinical Characteristics and Real-World Evaluation of the New Hampshire Hospital Screening and Referral Algorithm.
Stanciu CN, Timmons P, Fetter JC, Cano M
Prim Care Companion CNS Disord. 2026 Mar 31;28(2) pii: 25m04110. doi: 10.4088/PCC.25m04110. Epub 2026 Mar 31.
PMID: 41962019

Response to: Gorelick.
Hill K, Grundmann O, Smith KE, Stanciu CN
J Addict Med. 2025 May-Jun 01;19(3):345. doi: 10.1097/ADM.0000000000001418. Epub 2024 Nov 29.
PMID: 39621582

Kratom Consumption - The Tales of Three Patients.
Gnanasegaram SA, Sexton L, Stanciu CN
J Psychoactive Drugs. 2026 Jan-Mar;58(1):41-44. doi: 10.1080/02791072.2024.2424278. Epub 2024 Nov 4.
PMID: 39494665

Prevalence of Kratom Use Disorder Among Kratom Consumers.
Hill K, Grundmann O, Smith KE, Stanciu CN
J Addict Med. 2024 May-Jun 01;18(3):306-312. doi: 10.1097/ADM.0000000000001290. Epub 2024 Mar 5.
PMID: 38441236

Prevalence, Characteristics, and Reasons for Kratom Use among Psychiatrically Ill Inpatients Who Use Substances.
Stanciu CN, Ahmed S, Sarfraz Z, Nimavat N, Healey CJ, Grundmann O, Ballard JR, Henningfield J
J Dual Diagn. 2024 Apr-Jun;20(2):87-97. doi: 10.1080/15504263.2023.2289456. Epub 2023 Dec 28.
PMID: 38153407

The New Hampshire Hospital Screening and Referral Algorithm (NHHSRA) for Substance Use in People With Serious Mental Illness.
Stanciu CN, Healey CJ, Emeny RT, Aschbrenner K, Fetter JC, Friedman MJ
Prim Care Companion CNS Disord. 2023 May 18;25(3) pii: 22m03410. doi: 10.4088/PCC.22m03410. Epub 2023 May 18.
PMID: 37227394

Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.
Hill K, Gibson S, Grundmann O, Smith KE, Ballard J, Stanciu CN
Subst Abuse Treat Prev Policy. 2023 Apr 11;18(1):21. doi: 10.1186/s13011-023-00531-4. Epub 2023 Apr 11.
PMID: 37041624

The Impact of THC and CBD in Schizophrenia: A Systematic Review.
Ahmed S, Roth RM, Stanciu CN, Brunette MF
Front Psychiatry. 2021;12:694394. doi: 10.3389/fpsyt.2021.694394. Epub 2021 Jul 23.
PMID: 34366924

View more publications on PubMed